Updated Efficacy Results of ASKB589 Combined with CAPOX and PD-1 Inhibitor As First-Line Treatment for Metastatic Gastric/gastro-Esophageal Junction (G/GEJ) Adenocarcinoma from a Phase Ib/II Study.
Journal of Clinical Oncology（2025）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要